Healthcare & Medical Devices Global On demand · 24-48h

Global Vacutainer Blood Collection Tube Market Strategic Research Report

Global Vacutainer Blood Collection Tube Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Vacutainer Blood Collection Tube Market
$4.68B2025
7.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, Others

By Application: Hospital & Clinic, Third-Party Laboratory, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BD, Terumo, GBO, Nipro, Cardinal Health, Sekisui, Sarstedt, FL Medical, Hongyu Medical, Improve Medical, TUD, Sanli Medical, Gong Dong Medical, CDRICH, Xinle Medical, Lingen Precision Medical, WEGO, Kang Jian Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 141 pages
Market size 2025
$4.68B
Billion USD
Forecast CAGR
7.3%
2025-2032
Forecast 2032
$7.7B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Vacutainer Blood Collection Tube market size is predicted to grow from US$ 4,682 million in 2025 to US$ 7,594 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.

A vacutainer blood collection tube is a sterile glass or plastic tube with a closure that is evacuated to create a vacuum inside the tube facilitating the draw of a predetermined volume of liquid. Most commonly used to collect blood samples in venipuncture, they also used as urine collection tubes and as serum separator tubes. Vacutainer blood collection tubes may contain additives designed to stabilize and preserve the specimen prior to analytical testing. Tubes are available with or without a safety-engineered closure, with a variety of labeling options and closure colors as well as a range of draw volumes

One of the primary drivers of the Sterile Vacuum Blood Collection Tube market is the increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, which necessitate regular blood testing. The growing demand for diagnostic testing, coupled with advancements in medical technologies, has led to higher adoption rates of Sterile Vacuum Blood Collection Tubes in hospitals, clinics, and laboratories. Additionally, the rising global healthcare expenditure and awareness about early disease detection have further boosted the market. A significant challenge facing the Sterile Vacuum Blood Collection Tube market is the stringent regulatory environment and compliance requirements. Manufacturers must adhere to strict quality standards and undergo rigorous approval processes, which can delay product launches and increase operational costs. Moreover, the risk of contamination or improper handling during blood collection and transport poses a concern, making it essential for proper training and standardized procedures to ensure accurate and reliable test results.

In the global market, the core manufacturers of Venous Sterile Vacuum Blood Collection Tube are BD, GBO, Cardinal Health, etc. The top four players in the industry account for about 50% of the market share. Europe is the largest consumption place, with a consumption market share nearly 36.2% in 2023. Following Europe, North America is the second largest consumption place with the consumption market share of 28.7%.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vacutainer Blood Collection Tube market?

What factors are driving Vacutainer Blood Collection Tube market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vacutainer Blood Collection Tube market opportunities vary by end market size?

How does Vacutainer Blood Collection Tube break out by Type, by Application?

This report presents a comprehensive overview of the global Vacutainer Blood Collection Tube market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Serum Separating Tubes
  • EDTA Tubes
  • Plasma Separation Tubes
  • Others

Segment by Application

  • Hospital & Clinic
  • Third-Party Laboratory
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Vacutainer Blood Collection Tube market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital & Clinic, Third-Party Laboratory, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Vacutainer Blood Collection Tube Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$4.68B
2025
Forecast
$7.7B
2032
CAGR
7.3%
2025–2032
Régions
5
global
Key companies
BDTerumoGBONiproCardinal HealthSekisuiSarstedtFL Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Serum Separating TubesEDTA TubesPlasma Separation TubesOthers
By Application
Hospital & ClinicThird-Party LaboratoryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Serum Separating Tubes
  • 3.1.3 EDTA Tubes
  • 3.1.4 Plasma Separation Tubes
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital & Clinic
  • 4.1.3 Third-Party Laboratory
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Terumo
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 GBO
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Nipro
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cardinal Health
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Sekisui
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Sarstedt
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 FL Medical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Hongyu Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Improve Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 TUD
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Sanli Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Gong Dong Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 CDRICH
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Xinle Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Lingen Precision Medical
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 WEGO
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Kang Jian Medical
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Vacutainer Blood Collection Tube market size?
The global Vacutainer Blood Collection Tube market is estimated at US$ 4.68 billion in 2025 (base year) and is projected to reach US$ 7.59 billion by 2032.
What growth rate is expected for the Vacutainer Blood Collection Tube market through 2032?
The market is expected to grow at a CAGR of 7.3% from 2026 to 2032, expanding from US$ 4.68 billion in 2025 to US$ 7.59 billion in 2032, roughly 1.6 times its base-year value.
How is Vacutainer Blood Collection Tube defined?
A vacutainer blood collection tube is a sterile glass or plastic tube with a closure that is evacuated to create a vacuum inside the tube facilitating the draw of a predetermined volume of liquid. Most commonly used to collect blood samples in venipuncture, they also used as urine collection tubes and as serum separator tubes. Vacutainer blood collection tubes may contain additives designed to stabilize and preserve the specimen prior to analytical testing.
What are the main segments of the Vacutainer Blood Collection Tube market by type?
By type, the market is segmented into Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes and Others.
Which applications drive demand in the Vacutainer Blood Collection Tube market?
Key applications covered include Hospital & Clinic, Third-Party Laboratory and Others.
Who are the key players in the Vacutainer Blood Collection Tube market?
Key players profiled include BD, Terumo, GBO, Nipro, Cardinal Health, Sekisui, Sarstedt and FL Medical, among 18 companies covered in total.
Which regions and countries are covered for Vacutainer Blood Collection Tube?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Vacutainer Blood Collection Tube market?
Additionally, the rising global healthcare expenditure and awareness about early disease detection have further boosted the market.
What challenges does the Vacutainer Blood Collection Tube market face?
A significant challenge facing the Sterile Vacuum Blood Collection Tube market is the stringent regulatory environment and compliance requirements.
Who should buy the Vacutainer Blood Collection Tube market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital & Clinic, Third-Party Laboratory and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Vacutainer Blood Collection Tube market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.